December 18, 2024

Global Biopharmaceutical M&A and VC Insights

The life sciences industry continues to undergo significant transformation, with companies navigating through portfolio risks, pipeline challenges, public policy, and economic uncertainty. Our latest report reflects on mergers and acquisitions (M&A) trends and venture capital (VC) trends over the past year and provides considerations for biopharmaceutical companies heading into 2025. Discover the key insights below:

M&A activity has been subdued relative to 2023 with companies prioritizing growth and innovation
Acquirers continue to target pre-clinical therapeutics within oncology and central nervous systems (CNS) therapeutic areas
Cell and gene therapies (CGT) and anti-drug conjugates (ADCs) continue to be popular technology targets, with mRNA therapies gaining traction
VC dealmaking continues to remain steady, with 2024 deal volume tracking similarly to 2023
VC deals continue to concentrate around early-stage funding, reflecting a focus on novel innovative technologies
Biotech IPOs in 2024 to date have nearly doubled in volume relative to 2023, indicating acclimation to interest rates generally holding steady

Download the Report

Contact Us.

I acknowledge that A&M will process my personal information in accordance with its Privacy Notice.

Press Releases

ALVAREZ & MARSAL EYES EXPANSION OF GLOBAL TRANSACTION ANALYTICS UNIT WITH NEW SENIOR HIRE

June 26, 2025

Leading global professional services firm Alvarez & Marsal’s (A&M) Global Transaction Advisory Group (Global TAG) is heightening efforts to expand its Global Transaction Analytics (GTA) practice, welcoming Martine In ’t Veld as a Managing Director in New York.

Thought Leadership

Infrastructure Pulse Survey Report: Q2 2025

June 18, 2025

A&M and GIIA released the Infrastructure Pulse survey results biannually to provide a regular check of sentiment in the infrastructure investments sector and emerging trends across Europe, Australia and the Americas.

Thought Leadership

Using Culture and Leadership to Drive Change in a Merger Integration

June 17, 2025

Culture and leadership are among the most powerful drivers of merger integration success. Discover how a well-managed cultural and leadership integration can accelerate synergies, drive innovation and create a high-achieving organisation.

Thought Leadership

Media Buzz: 6 Moves to Add Value for Private Equity

June 9, 2025

In a recent article, A&M experts Jeff Shaffer and Kathleen Voss discuss the current M&E market and correlated opportunities for private equity groups.

Authors